WO1998040120A1 - Technique for adjusting the locus of excitation of electrically excitable tissue - Google Patents
Technique for adjusting the locus of excitation of electrically excitable tissue Download PDFInfo
- Publication number
- WO1998040120A1 WO1998040120A1 PCT/US1998/002841 US9802841W WO9840120A1 WO 1998040120 A1 WO1998040120 A1 WO 1998040120A1 US 9802841 W US9802841 W US 9802841W WO 9840120 A1 WO9840120 A1 WO 9840120A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pulse
- time
- suprathreshold
- electrode
- amplitude
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36071—Pain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36017—External stimulators, e.g. with patch electrodes with leads or electrodes penetrating the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/3615—Intensity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/36167—Timing, e.g. stimulation onset
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0551—Spinal or peripheral nerve electrodes
Definitions
- This invention relates to means of stimulating electrically excitable tissue, and more particularly relates to means for adjusting the locus at which action potentials are induced in such tissue.
- SCS pain control
- One is the difficulty of directing the stimulation-induced paresthesia to the desired body part and the other is the problem of disagreeable sensations or motor responses to the stimulation, which reduce the comfortable amplitude range of the stimulation. It is generally agreed that in SCS, for chronic pain, paresthesia should cover the whole pain region. With present stimulation methods and equipment, only highly skilled and experienced practitioners are able to position a stimulation lead in such a way that the desired overlap is reached and desired results are obtained over time with minimal side effects. It requires much time and effort to focus the stimulation on the desired body region during surgery and, with single channel approaches, it is difficult to redirect it afterwards, even though some readjustments can be made by selecting a different contact combination, pulse rate, pulse width or voltage.
- the electrodes in that prior art system are referred to as "in-line” electrodes that are disposed "symmetrically” along a line.
- the electrical field pattern across that line is adjusted by varying the electrical field generated between those electrodes along that line.
- the locus of excitation is correspondingly varied with that variation in the electrical field pattern.
- a lead such as a paddle is used for mounting the multiple electrodes in the optimally spaced positions. This lead is then inserted within a patient near the tissue to be excited with the electrical excitation applied to the lead.
- placement of a lead such as the paddle within a patient can be difficult since the paddle can be surgically difficult to manipulate adjacent the spinal cord.
- a primary object of the present invention is to provide a method and apparatus for adjusting the locus of excitation in electrically excitable tissue using electrodes that do not have to be optimally spaced in a line.
- an object of the present invention is to adjust areas of subthreshold excitation in order to adjust an area of superposition of such areas of subthreshold excitation.
- the area of supe osition determines the locus of excitation of electrically excitable tissue.
- the present invention takes the form of an apparatus and method for inducing action potentials at an adjustable locus of electrically excitable tissue.
- a first pulse having a first amplitude and a first pulse width is applied to the tissue via a first electrode adapted to be adjacent said tissue.
- a second pulse having a second amplitude and a second pulse width is applied to the tissue via a second electrode adapted to be adjacent said tissue.
- the application of the first pulse generates a first subthreshold potential area in said tissue
- the application of the second pulse generates a second subthreshold potential area.
- the first subthreshold area is determined by the first amplitude and the first pulse width of the first pulse
- the second subthreshold area is determined by the second amplitude and the second pulse width of the second pulse.
- a supe ⁇ osition of the first and second subthreshold areas results in a suprathreshold potential area of said adjustable locus where the action potentials are induced.
- This embodiment of the present invention may be applied to particular advantage when adjusting the locus where the action potentials are induced.
- the first amplitude or the first pulse width of the first pulse can be adjusted for a corresponding adjustment of the first subthreshold area and in turn the suprathreshold potential area.
- the second amplitude or the second pulse width of the second pulse can be adjusted for a corresponding adjustment of the second subthreshold area and in turn of the suprathreshold potential area. The size and location of the suprathreshold potential area can thus be controlled.
- a time delay between the application of the first and second pulses can be varied for a corresponding adjustment in size and location of the suprathreshold potential area.
- the time delay between the application of the first and second pulses can be measured from the end time of the first pulse to the begin time of the second pulse. Additionally, that delay can be measured as a difference between a first weighted average time of the first pulse and a second weighted average time of the second pulse, or between a first peak time of the first pulse and a second peak time of the second pulse.
- Figure 1 is a diagrammatic view of a patient in which a preferred form of apparatus for SCS made in accordance with the invention has been implanted;
- Figure 2 is a cross-sectional view of an exemplary spinal column showing a typical position at which electrodes made in accordance with the preferred practice of the invention have been implanted in the epidural space;
- Figure 3 is a cross-sectional view like Figure 2 showing locus of potential changes induced in cells of the spinal cord from a pulse applied to a first one of two electrodes;
- Figure 4 is a view like Figure 3 showing the locus of potential changes induced in cells of the spinal cord from the application of a pulse to the second of the electrodes;
- Figure 5 is a view like Figure 4 showing the combined loci in the spinal cord at which potential changes are induced from pulses applied to the first and second electrodes;
- Figure 6 is a view like Figure 5 showing the alteration of the loci due to increase in the amplitude of the pulse applied to the first electrode and a decrease in amplitude of the pulse applied to the second electrode;
- Figure 7 is a view like Figure 6 showing the alteration of the loci due to an increase in amplitude of the pulse applied to the second electrode and a decrease in amplitude of the pulse applied to the first electrode;
- Figure 8 is a timing diagram showing pulses applied to the first and second electrodes illustrated in Figure 2 in relationship to the potential changes induced in tissue adjacent the electrodes;
- Figures 9 and 10 are timing diagrams illustrating alternative forms of pulses applied to the electrodes illustrated in Figure 2;
- Figure 11 is a timing diagram illustrating a preferred form of pulses applied to the electrodes shown in Figure 2.
- Figure 12 shows the suprathreshold potential area generated from application of two pulses to two electrodes where the two pulses have a first time delay between the end of the first pulse and the start of the second pulse.
- Figure 13 shows the suprathreshold potential area generated from application of two pulses to two electrodes where the two pulses have a second time delay between the end of the first pulse and the start of the second pulse, with the second time delay being greater than the first time delay of Fig. 12.
- Figure 14 shows the suprathreshold potential area generated from application of two pulses to two electrodes where the two pulses have a third time delay between the end of the first pulse and the start of the second pulse, with the third time delay being greater than the second time delay of Fig. 13.
- Figure 15 shows the suprathreshold potential area generated from application of two pulses to two electrodes where the two pulses have a fourth time delay between the end of the first pulse and the start of the second pulse, with the fourth time delay being greater than the third time delay of Fig. 14.
- a single electrical pulse PI can cause depolarization near a cathode in electrically excitable tissue which includes neural tissue or muscle tissue.
- Neural tissue includes peripheral nerves, ganglia, the spinal cord surface, deep spinal cord tissue, deep brain tissue, and brain surface tissue.
- Muscle tissue includes skeletal (red) muscle, smooth (white) muscle, and cardiac muscle.
- a locus includes a set of points in three-dimensional space and refers to a volume of cells or parts of cells. Due to the electrical characteristics of both the three- dimensional volume conductor and the membrane properties, the potentials outside and inside a neuron respond to the depolarization, usually with exponential-type increases and then attenuation over time.
- the time constant for an isolated neuron membrane typically is 5-15 milliseconds (Nerve, Muscle and Synapse by Bernard Katz, circa 1972). For myelinated axons or muscle cells, it may be considerably shorter.
- a living cell at any time has a transmembrane potential across its membrane.
- This transmembrane potential is typically defined as the potential in the inside of the cell with respect to the outside of the cell.
- a living cell At rest, a living cell has a constant transmembrane potential called a resting potential of approximately -60mV to -90mV, with the inside of the cell being more negative than outside of the cell.
- a variety of changes to the environment of the living cell can result in a corresponding change in the transmembrane potential.
- a change in the environment that causes the inside of the cell to become less negative is referred to as a "depolarization" of the cell, and depolarization is then a positive change in the transmembrane potential.
- hypo ⁇ olarization a change in the environment that causes the inside of the cell to become more negative
- hype ⁇ olarization is a negative change in the transmembrane potential.
- An example change in the environment of a living cell is when a voltage pulse is applied near the cell. Depending on the direction of the electric current caused by this stimulation pulse, the pulse can be either depolarizing or hype ⁇ olarizing.
- Fig. 8 shows an example pulse PI that can cause depolarization in a cell, and this depolarization from application of pulse PI adjacent the cell can result in a transmembrane potential TPA between times Tl and T3 within the cell.
- a further application of another pulse P2 adjacent the cell results in a portion of the curve TPA between times T3 and T7.
- This portion of the curve is comprised of the supe ⁇ osition of the depolarization caused by pulse P2 and the remaining depolarization from the earlier application of pulse PI .
- This remaining depolarization from the prior application of pulse PI is shown by the dashed line curve between times T3 and T7.
- transmembrane potential TPA between times Tl and T3 is comprised of two components.
- the first component is the resting potential of the cell. This component is a constant gradient that exists across the membrane of the cell. Added to that first component is the depolarization that results from the application of pulse PI .
- transmembrane potential TPA during time Tl and T3 is the sum total of the resting potential with the depolarization effects from application of pulse PI.
- the sum total transmembrane potential TPA at any time must reach a transmembrane potential threshold in order for the electrically excitable cell to get an action potential induced therein.
- the peak of potential TPA is below the transmembrane potential threshold TPT, and potential TPA can be characterized as a subthreshold potential. As a result, the potential TPA fails to produce an action potential in that cell.
- Action potential is an all-or-none, nonlinear phenomenon, caused by opening of sodium gates, inrush of sodium ions, and a delayed opening of potassium gates and a restoration of the membrane potential.
- a certain amount of charge must be passed at the electrodes (amplitude [Volts] / resistance [Ohms] x pulse width [time]) in order to cause enough depolarization for an action potential to begin.
- rheobase There is a certain minimum voltage needed, called rheobase, before an action potential can happen.
- TPB transmembrane potential
- TPT transmembrane potential threshold
- TPB can be characterized as a suprathreshold potential
- the nerve tissue has an action potential started when TPB reaches the transmembrane potential threshold (at time T4).
- the transmembrane potential TPB is comprised of the constant resting potential and a depolarization that is sufficient enough to push the total transmembrane potential TPB above the transmembrane potential threshold.
- TPB at time T4 has sufficient depolarization to go above the transmembrane potential threshold because the amplitude of pulse P2 may have been larger than in the case of the subthreshold transmembrane potential TPA.
- Figure 1 is a schematic view of a patient 10 having an implant of a neurological stimulation system employing a preferred form of the present invention to stimulate spinal cord 12 of the patient.
- the preferred system employs an implantable pulse generator 14 to produce a number of independent stimulation pulses which are sent to spinal cord 12 by insulated leads 16 and 18 coupled to the spinal cord by electrodes 16A and 18A ( Figure 2). Electrodes 16A and 18A also can be attached to separate conductors included within a single lead.
- Implantable pulse generator 14 preferably is a modified ITREL II implantable pulse generator available from Medtronic, Inc. with provisions for multiple pulses occurring either simultaneously or with one pulse shifted in time with respect to the other, and having independently varying amplitudes and pulse widths.
- This preferred system employs a programmer 20 which is coupled via a conductor 22 to a radio frequency antenna 24. This system permits attending medical personnel to select the various pulse output options after implant using radio frequency communications. While the preferred system employs fully implanted elements, systems employing partially implanted generators and radio-frequency coupling may also be used in the practice of the present invention (e.g., similar to products sold by Medtronic, Inc. under the trademarks X-trel and Mattrix).
- Figure 2 is a cross-sectional view of spine 12 showing implantation of the distal end of insulated leads 16 and 18 which terminate in electrodes 16A and 18A within epidural space 26.
- the electrodes may be conventional percutaneous electrodes, such as PISCES® model 3487A sold by Medtronic, Inc. Also shown is the subdural space 28 filled with cerebrospinal fluid (cfs), bony vertebral body 30, vertebral arch 31, and dura mater 32.
- the spine also includes gray matter 34 and dorsal horns 36 and 37 and white matter, for example, dorsal columns 46 and dorsal lateral columns 47.
- Stimulation pulses are applied to electrodes 16A and 18A (which typically are cathodes) with respect to a return electrode (which typically is an anode) to induce a desired area of excitation in the spine 12 having nerve tissue capable of producing action potentials.
- a cathode has a more negative potential with respect to an anode, and the electrical current caused by the cathode tends to induce an action potential whereas the electrical current caused by the anode tends to inhibit an action potential.
- the return electrode for example a ground or other reference electrode, is also present but is not shown in the cross sectional view of spine 12 because the return electrode is located typically at a different plane from the shown cross section of Fig. 2.
- the return electrode may be located near a point up or down the line along the spinal column 12 or at a more remote part of the body 10 carrying the spine, such as at the metallic case of the pulse generator 14.
- more than one return electrode may be present in the body.
- There can be a respective return electrode for each cathode such that a distinct cathode/anode pair is formed for each cathode.
- pulse PI is applied to electrode 18A ( Figure 2) and pulse P2 is applied to electrode 16A ( Figure 2).
- Pulses PI and P2 have a timing relationship.
- pulses PI and P2 should not overlap in time.
- the end of pulse PI at time T2 and the start of pulse P2 at time T3 in Fig. 8 are displaced by a predetermined time period less than 500 microseconds, and preferably less than 50 microseconds.
- Amplitude Al of PI is adjustable independently from amplitude A2 of pulse P2.
- the pulse widths of pulses PI and P2 also are independently adjustable. Widening the pulse widths of each pulse (i.e., PI and P2) can also expand the loci of depolarizations, just like increasing amplitude, either voltage or current amplitude.
- the pulses PI and P2 also could have other time delay relationships in order to accomplish the goals of the present invention.
- pulses P3 and P4, having different rise times could be used.
- P3 has a rise time from Tl to T8 and P4 has a rise time from Tl to T9.
- pulses P5 and P6, having different fall times could be used.
- P5 has a fall time from T10 to Ti l
- P6 has a fall time from T10 to T12.
- the weighted average time WA3 of pulse P3 ( Figure 9) is displaced from the weighted average time WA4 of pulse P4 by a predetermined time period of less than 500 microseconds and preferably less than 50 microseconds.
- a weighted average time is the integral of a pulse over the pulse interval divided by the pulse amplitude of the pulse interval.
- the rise time and fall time of a pulse can affect the weighted average time of the pulse.
- the peak PK3 of pulse P3 is displaced from the peak PK4 of pulse P4 by a predetermined time period of less than 500 microseconds and preferably less than 50 microseconds.
- the rise time of a pulse can affect the peak time of the pulse.
- Objectives of the invention also can be achieved using combinations of the foregoing timing relationships.
- the time delay between the first pulse and the second pulse can be the time difference between a first weighted average time of the first pulse and a second weighted average time of the second pulse.
- the time delay can be the time difference between a first peak time of the first pulse and a second peak time of the second pulse.
- line LI represents the edge of a three-dimensional locus LI A in which pulse PI applied to electrode 18A results in a transmembrane potential which can be represented by the transmembrane potential curve, TPA of Fig. 8 (that part of the curve TPA between times Tl and T3 and the dashed line curve between times T3 and T7).
- That transmembrane potential is less than the transmembrane potential threshold TPT for cells of interest in that locus.
- That transmembrane potential is comprised of a constant resting potential and a depolarization caused by application of pulse PI to electrode 18 A.
- locus LI A which results from pulse PI being applied to electrode 18A without a recent pulse being applied to electrode 16A is an area having subthreshold potential since TPA is less than the transmembrane potential threshold.
- line L2 represents the edge of another three- dimensional locus L2A in which the application of pulse P2 to electrode 16A results in a transmembrane potential which also can be represented by the transmembrane potential curve, TPA of Fig. 8 (that part of the curve TPA between times Tl and T3 and the dashed line curve between times T3 and T7).
- That transmembrane potential is less than the transmembrane potential threshold TPT for cells of interest in that locus.
- That transmembrane potential is comprised of a constant resting potential and a depolarization caused by application of pulse P2 to electrode 16A.
- locus L2A which results from pulse P2 being applied to electrode 16A without a recent pulse being applied to electrode 18 A is also an area of subthreshold potential since TPA is less than the transmembrane potential threshold.
- FIG 5 illustrates a locus L3A representing the intersection of loci LI A and L2A in which the combined potentials induced in locus L3A from pulses PI and P2 create an action potential in cells of interest in locus L3A as illustrated by the transmembrane potential TPB in Figure 8.
- the total potential in locus LI A outside locus L3A is illustrated by the transmembrane potential TPA (that part of the curve TPA between times Tl and T3 and the dashed line curve between times T3 and T7 in Figure 8). Since TPA is lower than the transmembrane potential threshold TPT, the total potential is a subthreshold potential, and there is no action potential created in locus LI A outside L3A.
- the total potential created in locus in L2A outside L3A is also illustrated by transmembrane potential TPA (that part of the curve TPA between times Tl and T3 and the dashed line curve between times T3 and T7 in Figure 8).
- TPA transmembrane potential
- the total potential is a subthreshold potential, and there is no action potential created in locus L2A outside locus L3A.
- the suprathreshold potential induced in locus L3 A results from a supe ⁇ osition of the subthreshold potentials created in that area by excitation from a pulse applied to electrode 16A and from another pulse applied to electrode 18A.
- Locus L3A has nerve tissues that get action potentials resulting from this suprathreshold potential induced in that locus.
- the total potential in locus L3A is illustrated by the transmembrane potential TPB of Fig. 8. That transmembrane potential is comprised of the constant resting potential and the supe ⁇ osition of depolarizations from application of pulse PI to electrode 18A and pulse P2 to electrode 16A.
- line L4 represents the edge of another three-dimensional locus L4A having subthreshold potential resulting from the application of a pulse PI to electrode 18A having an amplitude greater than amplitude Al.
- Line L5 represents the edge of another three-dimensional locus L5A having subthreshold potential resulting from the application of a pulse P2 to electrode 16A having an amplitude less than amplitude A2.
- loci L4A and L5A creates a locus L6A in which a suprathreshold action potential results from a supe ⁇ osition of subthreshold potentials created by application of pulses PI and P2.
- Locus L6A is moved mostly to the right relative to locus L3A shown in Figure 5. Action potentials are not induced outside locus L6A since the area outside that locus has subthreshold potential.
- line L8 represents the edge of another three-dimensional locus L8A having subthreshold potential resulting from the application of a pulse P2 to electrode 16A having an amplitude greater than amplitude A2.
- Line L7 represents the edge of another three-dimensional locus L7 A having subthreshold potential resulting from the application of a pulse PI to electrode 18A having an amplitude less than amplitude Al .
- the intersection of loci L7A and L8A creates a locus L9A in which a suprathreshold action potential is induced from a supe ⁇ osition of subthreshold potentials created by application of both pulses PI and P2. It will be noted that the locus L9A is moved to the left compared with locus L3A shown in Figure 5. Action potentials are not induced outside locus L9A since the area outside that locus has subthreshold potential.
- a benefit of utilizing the neurophysiological principle of "electrotonus” is that the area of suprathreshold potential can be controlled by varying the time delay between application of the two pulses to each respective driven electrode for creating the areas of subthreshold potential. Referring to Fig. 8, this time delay can be the time period between the end of pulse PI at time T2 and the start of pulse P2 at time T3.
- the transmembrane potential created within a nerve cell by a pulse starts to decay at the end of the excitation pulse, and this transmembrane potential is a function of time.
- the area of suprathreshold potential can be adjusted by correspondingly varying the time delay between the pulses that are applied to two electrodes that each produce a subthreshold area.
- FIG. 12 illustrates the case where the pulses applied to the two cathodes follow closely in time.
- Element 12 is a simplified illustration of electrically excitable tissue such as spinal column tissue. Pulse P2 immediately follows after the end of pulse PI, and the time delay between the end of pulse PI at T2 and the start of pulse P2 at T3 is small in this case.
- Line L10 represents the isopotential line defining a subthreshold area L10A created by application of pulse PI at electrode 18 A.
- Line Ll l represents the isopotential line defining another subthreshold area LI 1A created by application of pulse P2 at electrode 16 A.
- Each isopotential line varies with time and progresses away from the electrode producing that isopotential line during the application of a pulse to that electrode and recedes back toward that electrode after the completion of the pulse by the principle of "electrotonus".
- the isopotential lines L10 and LI 1 are what result at the end of pulse P2 at time T4. These individual subthreshold areas by themselves do not have sufficient potential changes to induce an action potential within tissue 12.
- a supe ⁇ osition of the subthreshold potential areas at time T4 creates an area L12A of suprathreshold potential that is greater than the transmembrane potential threshold such that nerve cells within that area have an action potential induced therein.
- Fig. 13 shows a case where the two pulses PI and P2 are more separated in time than the case illustrated in Fig. 12.
- the transmembrane potentials in Fig. 13 that are created in electrically excitable tissue 12 are those that remain at the end of pulse P2 at time T4.
- Isopotential line LI 3 defines the subthreshold area L13A that remains from the application of pulse PI to electrode 18A by time T4.
- Isopotential line L14 defines the subthreshold area L14A that is created by application of pulse P2 to electrode 16A by time T4.
- Fig. 14 shows a case where the two pulses PI and P2 are still even more separated in time than those of Fig. 13.
- Fig. 14 shows the isopotential lines that are created by pulses PI and P2 at the end of pulse P2 at time T4.
- the isopotential line LI 6 defines the subthreshold area L16A created by the application of pulse PI at electrode 18 A by time T4
- the isopotential line LI 7 defines the subthreshold area L17A created by the application of pulse P2 at electrode 16A by time T4.
- isopotential lines LI 6 and LI 7 by themselves do not have sufficient potential changes to induce an action potential.
- a supe ⁇ osition of subthreshold potential areas creates an area L18A of suprathreshold potential that is greater than the transmembrane potential threshold such that nerve cells within that area have an action potential induced therein.
- isopotential line LI 6 has receded further toward electrode 18A by the end of pulse P2 at time T4, and the area LI 8 A of suprathreshold potential has decreased and has shifted more toward electrode 18 A.
- Fig. 15 shows a case where pulse PI and P2 have a time delay sufficiently far enough such that no area of suprathreshold potential is created within the electrically excitable tissue 12.
- Isopotential line LI 9 is the result of application of pulse PI at electrode 18A by the end of pulse P2 at time T4, and isopotential line L20 is the result of application of pulse P2 at electrode 16A by time T4. Because of the large delay between pulses PI and P2, isopotential line LI 9 has receded so far back toward electrode 18A that there is no area of supe ⁇ osition of the two subthreshold areas created by isopotential lines LI 9 and L20 within tissue 12.
- the locus in which action potentials are induced can be manipulated to a desired area of the dorsal columns 46 without inducing action potentials in dorsal horns 36 and 37, gray matter 34 or dorsal lateral columns 47 or dorsal root ganglia 38 and 40.
- the ability to move the locus in which action potentials are induced drastically reduces the accuracy necessary for surgically implanting electrodes 16A and 18 A, and may eliminate the need for surgical lead revisions.
- pulse P8 applied to electrode 16 A.
- Currently available pulse generators use a biphasic pulse to insure no net direct current flows into the tissue. This is known as charge-balanced pulsing, and is accomplished by driving the pulse negative for a duration of time.
- pulse P8 has a net charge delivered proportional to A2*(T4-T3).
- This injected charge is balanced by the negative pulse P10, whose charge is proportional to A3*(T5-T4), where A3 «A2 and (T5-T4)»(T4-T3). Similar principles apply even if the first and second pulses are not of constant amplitude.
- pulse P7 may be generated with a trailing negative pulse P9 from time T4 to time T5, so that the output on electrode 18A is substantially at neutral or 0 potential until the termination of pulse P8 at time T4. Having this delay in charge balancing prevents the loss of potential in adjacent tissue that otherwise would occur if pulse P9 immediately followed pulse P7 and overlapped with pulse P8, thus offsetting the benefit of pulse P8.
- both negative pulses P9 and P10 begin in order to maintain the charge balance in tissue adjacent to the respective electrodes 18A and 16 A.
- the invention can be generalized to using more than two cathodal electrodes to generate more than two subthreshold areas to be supe ⁇ osed in generating the suprathreshold potential area. Accordingly, the forgoing description is by way of example only and is not intended to be limiting. The invention is limited only as defined in the following claims and equivalents thereof.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Electrotherapy Devices (AREA)
Abstract
The locus of electrically excitable tissue where action potentials are induced, can be controlled. A first pulse (P1) having a first amplitude and a first pulse width is applied to a first electrode (18A) adjacent the tissue to generate a first subthreshold potential area (L10A) within the tissue. A second pulse (P2) having a second amplitude and a second pulse width is applied to a second electrode (16A) adapted to be adjacent the tissue to generate a second subthreshold potential area (L11A) within the tissue. The locus (L12A) within the tissue where action potentials are induced is determined by a superposition of the first and second subthreshold areas according to the physiological principle of electrotonus. The location and size of this locus can be controlled by adjusting at least one of the first and second amplitudes and the first and second pulse widths or the time delay between the first and second pulses.
Description
TECHNIQUE FOR ADJUSTING THE LOCUS OF EXCITATION OF ELECTRICALLY EXCITABLE TISSUE
BACKGROUND OF THE INVENTION
This is a continuation-in-part of the earlier filed copending patent application, Serial No. 08/627,578 filed on April 4, 1996, for which priority is claimed. This parent application is incorporated herewith by reference. Field of the Invention
This invention relates to means of stimulating electrically excitable tissue, and more particularly relates to means for adjusting the locus at which action potentials are induced in such tissue.
Description of the Related Art Two major practical problems reduce the efficacy of epidural spinal cord stimulation
(SCS) for pain control. One is the difficulty of directing the stimulation-induced paresthesia to the desired body part and the other is the problem of disagreeable sensations or motor responses to the stimulation, which reduce the comfortable amplitude range of the stimulation. It is generally agreed that in SCS, for chronic pain, paresthesia should cover the whole pain region. With present stimulation methods and equipment, only highly skilled and experienced practitioners are able to position a stimulation lead in such a way that the desired overlap is reached and desired results are obtained over time with minimal side effects. It requires much time and effort to focus the stimulation on the desired body region during surgery and, with single channel approaches, it is difficult to redirect it afterwards, even though some readjustments can be made by selecting a different contact combination, pulse rate, pulse width or voltage.
Redirecting paresthesia after surgery is highly desirable. Even if paresthesia covers the pain area perfectly during surgery, the required paresthesia pattern often changes later due to lead migration, or histological changes (such as the growth of connective tissue around the stimulation electrode) or disease progression. The problem of lead placement has been addressed by U.S. Patent No. 5,121,754 by the use of a lead with a deformable distal shape. These problems are not only found with SCS, but also with peripheral nerve stimulation (PNS), depth brain stimulation (DBS), cortical stimulation and also muscle or cardiac stimulation.
A system capable of some adjustment of spinal cord excitation is described in PCT
International Publication No. WO 95/19804 (counterpart to Holsheimer et al., U.S. Patent No. 5,501,703 ). However, that system requires three electrodes, optimally spaced, which is a serious handicap during the surgical procedure required in order to place these electrodes in the body. That system steers the locus of excitation by varying the potentials between the electrodes that are optimally spaced in a line.
In fact, the electrodes in that prior art system are referred to as "in-line" electrodes that are disposed "symmetrically" along a line. The electrical field pattern across that line is adjusted by varying the electrical field generated between those electrodes along that line. The locus of excitation is correspondingly varied with that variation in the electrical field pattern. Thus, because U. S. Patent No. 5,501,703 to Holsheimer et al. requires multiple electrodes optimally spaced symmetrically along a line, a lead such as a paddle is used for mounting the multiple electrodes in the optimally spaced positions. This lead is then inserted within a patient near the tissue to be excited with the electrical excitation applied to the lead. Unfortunately, placement of a lead such as the paddle within a patient, can be difficult since the paddle can be surgically difficult to manipulate adjacent the spinal cord.
Thus, it would be desirable to be able to adjust the locus of excitation in electrically excitable tissue without the use of optimally spaced electrodes.
Objects of the Invention Accordingly, a primary object of the present invention is to provide a method and apparatus for adjusting the locus of excitation in electrically excitable tissue using electrodes that do not have to be optimally spaced in a line.
In particular, an object of the present invention is to adjust areas of subthreshold excitation in order to adjust an area of superposition of such areas of subthreshold excitation. The area of supe osition determines the locus of excitation of electrically excitable tissue.
SUMMARY OF THE INVENTION
In a principle aspect, the present invention takes the form of an apparatus and method for inducing action potentials at an adjustable locus of electrically excitable tissue. In accordance with the invention, a first pulse having a first amplitude and a first pulse width is applied to the tissue via a first electrode adapted to be adjacent said tissue. Similarly, a second pulse having
a second amplitude and a second pulse width is applied to the tissue via a second electrode adapted to be adjacent said tissue.
The application of the first pulse generates a first subthreshold potential area in said tissue, and the application of the second pulse generates a second subthreshold potential area. The first subthreshold area is determined by the first amplitude and the first pulse width of the first pulse, and the second subthreshold area is determined by the second amplitude and the second pulse width of the second pulse. A supeφosition of the first and second subthreshold areas results in a suprathreshold potential area of said adjustable locus where the action potentials are induced. This embodiment of the present invention may be applied to particular advantage when adjusting the locus where the action potentials are induced. The first amplitude or the first pulse width of the first pulse can be adjusted for a corresponding adjustment of the first subthreshold area and in turn the suprathreshold potential area. Similarly, the second amplitude or the second pulse width of the second pulse can be adjusted for a corresponding adjustment of the second subthreshold area and in turn of the suprathreshold potential area. The size and location of the suprathreshold potential area can thus be controlled.
In another aspect of the present invention, a time delay between the application of the first and second pulses can be varied for a corresponding adjustment in size and location of the suprathreshold potential area. The time delay between the application of the first and second pulses can be measured from the end time of the first pulse to the begin time of the second pulse. Additionally, that delay can be measured as a difference between a first weighted average time of the first pulse and a second weighted average time of the second pulse, or between a first peak time of the first pulse and a second peak time of the second pulse.
These and other features and advantages of the present invention will be better understood by considering the following detailed description of the invention which is presented with the attached drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
These and other advantages and features of the invention will become apparent upon reading the following detailed description and referring to the accompanying drawings in which
like numbers refer to like parts throughout and in which:
Figure 1 is a diagrammatic view of a patient in which a preferred form of apparatus for SCS made in accordance with the invention has been implanted;
Figure 2 is a cross-sectional view of an exemplary spinal column showing a typical position at which electrodes made in accordance with the preferred practice of the invention have been implanted in the epidural space;
Figure 3 is a cross-sectional view like Figure 2 showing locus of potential changes induced in cells of the spinal cord from a pulse applied to a first one of two electrodes;
Figure 4 is a view like Figure 3 showing the locus of potential changes induced in cells of the spinal cord from the application of a pulse to the second of the electrodes;
Figure 5 is a view like Figure 4 showing the combined loci in the spinal cord at which potential changes are induced from pulses applied to the first and second electrodes;
Figure 6 is a view like Figure 5 showing the alteration of the loci due to increase in the amplitude of the pulse applied to the first electrode and a decrease in amplitude of the pulse applied to the second electrode;
Figure 7 is a view like Figure 6 showing the alteration of the loci due to an increase in amplitude of the pulse applied to the second electrode and a decrease in amplitude of the pulse applied to the first electrode;
Figure 8 is a timing diagram showing pulses applied to the first and second electrodes illustrated in Figure 2 in relationship to the potential changes induced in tissue adjacent the electrodes;
Figures 9 and 10 are timing diagrams illustrating alternative forms of pulses applied to the electrodes illustrated in Figure 2; and
Figure 11 is a timing diagram illustrating a preferred form of pulses applied to the electrodes shown in Figure 2.
Figure 12 shows the suprathreshold potential area generated from application of two pulses to two electrodes where the two pulses have a first time delay between the end of the first pulse and the start of the second pulse.
Figure 13 shows the suprathreshold potential area generated from application of two pulses to two electrodes where the two pulses have a second time delay between the end of the
first pulse and the start of the second pulse, with the second time delay being greater than the first time delay of Fig. 12.
Figure 14 shows the suprathreshold potential area generated from application of two pulses to two electrodes where the two pulses have a third time delay between the end of the first pulse and the start of the second pulse, with the third time delay being greater than the second time delay of Fig. 13.
Figure 15 shows the suprathreshold potential area generated from application of two pulses to two electrodes where the two pulses have a fourth time delay between the end of the first pulse and the start of the second pulse, with the fourth time delay being greater than the third time delay of Fig. 14.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
Referring to Figure 8, a single electrical pulse PI can cause depolarization near a cathode in electrically excitable tissue which includes neural tissue or muscle tissue. Neural tissue includes peripheral nerves, ganglia, the spinal cord surface, deep spinal cord tissue, deep brain tissue, and brain surface tissue. Muscle tissue includes skeletal (red) muscle, smooth (white) muscle, and cardiac muscle. A locus includes a set of points in three-dimensional space and refers to a volume of cells or parts of cells. Due to the electrical characteristics of both the three- dimensional volume conductor and the membrane properties, the potentials outside and inside a neuron respond to the depolarization, usually with exponential-type increases and then attenuation over time. The time constant for an isolated neuron membrane typically is 5-15 milliseconds (Nerve, Muscle and Synapse by Bernard Katz, circa 1972). For myelinated axons or muscle cells, it may be considerably shorter.
A living cell at any time has a transmembrane potential across its membrane. This transmembrane potential is typically defined as the potential in the inside of the cell with respect to the outside of the cell. At rest, a living cell has a constant transmembrane potential called a resting potential of approximately -60mV to -90mV, with the inside of the cell being more negative than outside of the cell. A variety of changes to the environment of the living cell can result in a corresponding change in the transmembrane potential. A change in the environment that causes the inside of the cell to become less negative is
referred to as a "depolarization" of the cell, and depolarization is then a positive change in the transmembrane potential. Similarly, a change in the environment that causes the inside of the cell to become more negative is referred to as a "hypeφolarization" of the cell, and hypeφolarization is a negative change in the transmembrane potential. An example change in the environment of a living cell is when a voltage pulse is applied near the cell. Depending on the direction of the electric current caused by this stimulation pulse, the pulse can be either depolarizing or hypeφolarizing.
Fig. 8 shows an example pulse PI that can cause depolarization in a cell, and this depolarization from application of pulse PI adjacent the cell can result in a transmembrane potential TPA between times Tl and T3 within the cell. A further application of another pulse P2 adjacent the cell results in a portion of the curve TPA between times T3 and T7. This portion of the curve is comprised of the supeφosition of the depolarization caused by pulse P2 and the remaining depolarization from the earlier application of pulse PI . This remaining depolarization from the prior application of pulse PI is shown by the dashed line curve between times T3 and T7.
The transmembrane potential TPA between times Tl and T3 is comprised of two components. The first component is the resting potential of the cell. This component is a constant gradient that exists across the membrane of the cell. Added to that first component is the depolarization that results from the application of pulse PI . Thus, transmembrane potential TPA during time Tl and T3 is the sum total of the resting potential with the depolarization effects from application of pulse PI.
The sum total transmembrane potential TPA at any time must reach a transmembrane potential threshold in order for the electrically excitable cell to get an action potential induced therein. The peak of potential TPA is below the transmembrane potential threshold TPT, and potential TPA can be characterized as a subthreshold potential. As a result, the potential TPA fails to produce an action potential in that cell.
Action potential is an all-or-none, nonlinear phenomenon, caused by opening of sodium gates, inrush of sodium ions, and a delayed opening of potassium gates and a restoration of the membrane potential. In general, a certain amount of charge must be passed at the electrodes (amplitude [Volts] / resistance [Ohms] x pulse width [time]) in order to cause enough
depolarization for an action potential to begin. There is a reciprocal relationship between amplitude and pulse width: the product must reach a certain value before the transmembrane potential threshold is reached. This relationship does not reach the Volts = 0 axis. There is a certain minimum voltage needed, called rheobase, before an action potential can happen. Basic neurophysiological principles, called "electrotonus", show that in any volume of electrically excitable tissue in which two or more depolarizing pulses tending to induce action potentials, each of which alone is insufficient to bring the cells to threshold, arrive closely together in time, at least part of their effect is additive, i.e., the memory of the first pulse is still present when the second pulse arrives. If the sum of the potentials (distorted by resistive and capacitive properties of the surroundings and the cell membranes) can get some cells depolarized to threshold, then an action potential will start in those cells. A reference that explains these principles of "electrotonus" including the creation of subthreshold potentials is Medical Physiology. 13th Edition, Vol. 1, by Vernon B. Mountcastle, C. V. Mosby Co., 1974.
Still referring to Figure 8, the inducement of an action potential in a cell is illustrated by a transmembrane potential TPB reaching the transmembrane potential threshold TPT at time T4. TPB can be characterized as a suprathreshold potential, and the nerve tissue has an action potential started when TPB reaches the transmembrane potential threshold (at time T4). The transmembrane potential TPB is comprised of the constant resting potential and a depolarization that is sufficient enough to push the total transmembrane potential TPB above the transmembrane potential threshold. TPB at time T4 has sufficient depolarization to go above the transmembrane potential threshold because the amplitude of pulse P2 may have been larger than in the case of the subthreshold transmembrane potential TPA.
Figure 1 is a schematic view of a patient 10 having an implant of a neurological stimulation system employing a preferred form of the present invention to stimulate spinal cord 12 of the patient. The preferred system employs an implantable pulse generator 14 to produce a number of independent stimulation pulses which are sent to spinal cord 12 by insulated leads 16 and 18 coupled to the spinal cord by electrodes 16A and 18A (Figure 2). Electrodes 16A and 18A also can be attached to separate conductors included within a single lead.
Implantable pulse generator 14 preferably is a modified ITREL II implantable pulse generator available from Medtronic, Inc. with provisions for multiple pulses occurring either
simultaneously or with one pulse shifted in time with respect to the other, and having independently varying amplitudes and pulse widths. This preferred system employs a programmer 20 which is coupled via a conductor 22 to a radio frequency antenna 24. This system permits attending medical personnel to select the various pulse output options after implant using radio frequency communications. While the preferred system employs fully implanted elements, systems employing partially implanted generators and radio-frequency coupling may also be used in the practice of the present invention (e.g., similar to products sold by Medtronic, Inc. under the trademarks X-trel and Mattrix).
Figure 2 is a cross-sectional view of spine 12 showing implantation of the distal end of insulated leads 16 and 18 which terminate in electrodes 16A and 18A within epidural space 26. The electrodes may be conventional percutaneous electrodes, such as PISCES® model 3487A sold by Medtronic, Inc. Also shown is the subdural space 28 filled with cerebrospinal fluid (cfs), bony vertebral body 30, vertebral arch 31, and dura mater 32. The spine also includes gray matter 34 and dorsal horns 36 and 37 and white matter, for example, dorsal columns 46 and dorsal lateral columns 47.
Stimulation pulses are applied to electrodes 16A and 18A (which typically are cathodes) with respect to a return electrode (which typically is an anode) to induce a desired area of excitation in the spine 12 having nerve tissue capable of producing action potentials. (A cathode has a more negative potential with respect to an anode, and the electrical current caused by the cathode tends to induce an action potential whereas the electrical current caused by the anode tends to inhibit an action potential.) The return electrode, for example a ground or other reference electrode, is also present but is not shown in the cross sectional view of spine 12 because the return electrode is located typically at a different plane from the shown cross section of Fig. 2. For example, the return electrode may be located near a point up or down the line along the spinal column 12 or at a more remote part of the body 10 carrying the spine, such as at the metallic case of the pulse generator 14. Alternatively, more than one return electrode may be present in the body. There can be a respective return electrode for each cathode such that a distinct cathode/anode pair is formed for each cathode.
Referring to Figure 8, pulse PI is applied to electrode 18A (Figure 2) and pulse P2 is applied to electrode 16A (Figure 2). Pulses PI and P2 have a timing relationship. For optimal
operation of the present invention with the application of the principle of "electrotonus", pulses PI and P2 should not overlap in time. For example, the end of pulse PI at time T2 and the start of pulse P2 at time T3 in Fig. 8 are displaced by a predetermined time period less than 500 microseconds, and preferably less than 50 microseconds. Amplitude Al of PI is adjustable independently from amplitude A2 of pulse P2. The pulse widths of pulses PI and P2 also are independently adjustable. Widening the pulse widths of each pulse (i.e., PI and P2) can also expand the loci of depolarizations, just like increasing amplitude, either voltage or current amplitude.
The pulses PI and P2 also could have other time delay relationships in order to accomplish the goals of the present invention. Referring to Figure 9, pulses P3 and P4, having different rise times, could be used. P3 has a rise time from Tl to T8 and P4 has a rise time from Tl to T9. Referring to Figure 10, pulses P5 and P6, having different fall times, could be used. P5 has a fall time from T10 to Ti l, and P6 has a fall time from T10 to T12. The weighted average time WA3 of pulse P3 (Figure 9) is displaced from the weighted average time WA4 of pulse P4 by a predetermined time period of less than 500 microseconds and preferably less than 50 microseconds. A weighted average time is the integral of a pulse over the pulse interval divided by the pulse amplitude of the pulse interval. The rise time and fall time of a pulse can affect the weighted average time of the pulse.
Similarly, the peak PK3 of pulse P3 is displaced from the peak PK4 of pulse P4 by a predetermined time period of less than 500 microseconds and preferably less than 50 microseconds. The rise time of a pulse can affect the peak time of the pulse. Objectives of the invention also can be achieved using combinations of the foregoing timing relationships. For example, the time delay between the first pulse and the second pulse can be the time difference between a first weighted average time of the first pulse and a second weighted average time of the second pulse. Alternatively, the time delay can be the time difference between a first peak time of the first pulse and a second peak time of the second pulse.
Referring to Figures 3 and 8, line LI represents the edge of a three-dimensional locus LI A in which pulse PI applied to electrode 18A results in a transmembrane potential which can be represented by the transmembrane potential curve, TPA of Fig. 8 (that part of the curve TPA between times Tl and T3 and the dashed line curve between times T3 and T7). That
transmembrane potential is less than the transmembrane potential threshold TPT for cells of interest in that locus. That transmembrane potential is comprised of a constant resting potential and a depolarization caused by application of pulse PI to electrode 18 A. Thus, locus LI A, which results from pulse PI being applied to electrode 18A without a recent pulse being applied to electrode 16A is an area having subthreshold potential since TPA is less than the transmembrane potential threshold.
Similarly, referring to Figures 4 and 8, line L2 represents the edge of another three- dimensional locus L2A in which the application of pulse P2 to electrode 16A results in a transmembrane potential which also can be represented by the transmembrane potential curve, TPA of Fig. 8 (that part of the curve TPA between times Tl and T3 and the dashed line curve between times T3 and T7). That transmembrane potential is less than the transmembrane potential threshold TPT for cells of interest in that locus. That transmembrane potential is comprised of a constant resting potential and a depolarization caused by application of pulse P2 to electrode 16A. Thus, locus L2A, which results from pulse P2 being applied to electrode 16A without a recent pulse being applied to electrode 18 A is also an area of subthreshold potential since TPA is less than the transmembrane potential threshold.
Figure 5 illustrates a locus L3A representing the intersection of loci LI A and L2A in which the combined potentials induced in locus L3A from pulses PI and P2 create an action potential in cells of interest in locus L3A as illustrated by the transmembrane potential TPB in Figure 8. The total potential in locus LI A outside locus L3A is illustrated by the transmembrane potential TPA (that part of the curve TPA between times Tl and T3 and the dashed line curve between times T3 and T7 in Figure 8). Since TPA is lower than the transmembrane potential threshold TPT, the total potential is a subthreshold potential, and there is no action potential created in locus LI A outside L3A. The total potential created in locus in L2A outside L3A is also illustrated by transmembrane potential TPA (that part of the curve TPA between times Tl and T3 and the dashed line curve between times T3 and T7 in Figure 8). The total potential is a subthreshold potential, and there is no action potential created in locus L2A outside locus L3A.
The suprathreshold potential induced in locus L3 A results from a supeφosition of the subthreshold potentials created in that area by excitation from a pulse applied to electrode 16A and from another pulse applied to electrode 18A. Locus L3A has nerve tissues that get action
potentials resulting from this suprathreshold potential induced in that locus. The total potential in locus L3A is illustrated by the transmembrane potential TPB of Fig. 8. That transmembrane potential is comprised of the constant resting potential and the supeφosition of depolarizations from application of pulse PI to electrode 18A and pulse P2 to electrode 16A. Referring to Figures 6 and 8, line L4 represents the edge of another three-dimensional locus L4A having subthreshold potential resulting from the application of a pulse PI to electrode 18A having an amplitude greater than amplitude Al. Line L5 represents the edge of another three-dimensional locus L5A having subthreshold potential resulting from the application of a pulse P2 to electrode 16A having an amplitude less than amplitude A2. The intersection of loci L4A and L5A creates a locus L6A in which a suprathreshold action potential results from a supeφosition of subthreshold potentials created by application of pulses PI and P2. Locus L6A is moved mostly to the right relative to locus L3A shown in Figure 5. Action potentials are not induced outside locus L6A since the area outside that locus has subthreshold potential.
Referring to Figures 7 and 8, line L8 represents the edge of another three-dimensional locus L8A having subthreshold potential resulting from the application of a pulse P2 to electrode 16A having an amplitude greater than amplitude A2. Line L7 represents the edge of another three-dimensional locus L7 A having subthreshold potential resulting from the application of a pulse PI to electrode 18A having an amplitude less than amplitude Al . The intersection of loci L7A and L8A creates a locus L9A in which a suprathreshold action potential is induced from a supeφosition of subthreshold potentials created by application of both pulses PI and P2. It will be noted that the locus L9A is moved to the left compared with locus L3A shown in Figure 5. Action potentials are not induced outside locus L9A since the area outside that locus has subthreshold potential.
A benefit of utilizing the neurophysiological principle of "electrotonus" is that the area of suprathreshold potential can be controlled by varying the time delay between application of the two pulses to each respective driven electrode for creating the areas of subthreshold potential. Referring to Fig. 8, this time delay can be the time period between the end of pulse PI at time T2 and the start of pulse P2 at time T3.
Principles of "electrotonus" indicate that a potential for any nerve cell decays with a RC time constant after a stimulation pulse has been applied to that nerve cell. R is a resistive value
determined by the resistive characteristic for that nerve cell, and C is a capacitive value determined by the capacitive characteristic for that nerve cell.
Because of this memory effect of electrotonus, the transmembrane potential created within a nerve cell by a pulse starts to decay at the end of the excitation pulse, and this transmembrane potential is a function of time. By taking advantage of this time variation of the transmembrane potential, the area of suprathreshold potential can be adjusted by correspondingly varying the time delay between the pulses that are applied to two electrodes that each produce a subthreshold area.
This benefit is further illustrated in Figures 12-15 where elements similar to elements in the prior figures are labeled with the same numeric label. Fig. 12 illustrates the case where the pulses applied to the two cathodes follow closely in time. Element 12 is a simplified illustration of electrically excitable tissue such as spinal column tissue. Pulse P2 immediately follows after the end of pulse PI, and the time delay between the end of pulse PI at T2 and the start of pulse P2 at T3 is small in this case. Line L10 represents the isopotential line defining a subthreshold area L10A created by application of pulse PI at electrode 18 A. Line Ll l represents the isopotential line defining another subthreshold area LI 1A created by application of pulse P2 at electrode 16 A. (A return electrode is not shown in Figs. 12-15 since that electrode is typically located on a different plane from the shown tissue plane 12 or on a more remote location on the body carrying the tissue 12 such as at the metallic case of the pulse generator 14 of Fig. 1.) Each isopotential line varies with time and progresses away from the electrode producing that isopotential line during the application of a pulse to that electrode and recedes back toward that electrode after the completion of the pulse by the principle of "electrotonus". In Fig. 12, the isopotential lines L10 and LI 1 are what result at the end of pulse P2 at time T4. These individual subthreshold areas by themselves do not have sufficient potential changes to induce an action potential within tissue 12. However, a supeφosition of the subthreshold potential areas at time T4 creates an area L12A of suprathreshold potential that is greater than the transmembrane potential threshold such that nerve cells within that area have an action potential induced therein.
Fig. 13 shows a case where the two pulses PI and P2 are more separated in time than the case illustrated in Fig. 12. The transmembrane potentials in Fig. 13 that are created in
electrically excitable tissue 12 are those that remain at the end of pulse P2 at time T4. By that time, the application of pulse PI was already completed at time T2. Isopotential line LI 3 defines the subthreshold area L13A that remains from the application of pulse PI to electrode 18A by time T4. Isopotential line L14 defines the subthreshold area L14A that is created by application of pulse P2 to electrode 16A by time T4.
These individual subthreshold areas by themselves do not have sufficient potential changes to induce an action potential. However, a supeφosition of the subthreshold potential areas creates an area LI 5 A of suprathreshold potential that is greater than the transmembrane potential threshold such that nerve cells within that area have an action potential induced therein. Note that the area of suprathreshold potential LI 5 A of Fig. 13 differs from the area of suprathreshold potential L12A of Fig. 12 because of the larger time delay between the end of pulse PI at T2 and the start of pulse P2 at T3 in Fig. 13 than in Fig. 12.
Similarly, Fig. 14 shows a case where the two pulses PI and P2 are still even more separated in time than those of Fig. 13. Fig. 14 shows the isopotential lines that are created by pulses PI and P2 at the end of pulse P2 at time T4. The isopotential line LI 6 defines the subthreshold area L16A created by the application of pulse PI at electrode 18 A by time T4, and the isopotential line LI 7 defines the subthreshold area L17A created by the application of pulse P2 at electrode 16A by time T4.
The individual subthreshold areas within isopotential lines LI 6 and LI 7 by themselves do not have sufficient potential changes to induce an action potential. However, a supeφosition of subthreshold potential areas creates an area L18A of suprathreshold potential that is greater than the transmembrane potential threshold such that nerve cells within that area have an action potential induced therein. Note that because of the larger delay between pulses PI and P2, isopotential line LI 6 has receded further toward electrode 18A by the end of pulse P2 at time T4, and the area LI 8 A of suprathreshold potential has decreased and has shifted more toward electrode 18 A.
Finally, Fig. 15 shows a case where pulse PI and P2 have a time delay sufficiently far enough such that no area of suprathreshold potential is created within the electrically excitable tissue 12. Isopotential line LI 9 is the result of application of pulse PI at electrode 18A by the end of pulse P2 at time T4, and isopotential line L20 is the result of application of pulse P2 at
electrode 16A by time T4. Because of the large delay between pulses PI and P2, isopotential line LI 9 has receded so far back toward electrode 18A that there is no area of supeφosition of the two subthreshold areas created by isopotential lines LI 9 and L20 within tissue 12.
The ability to move the locus in which action potentials are induced by controlling the area of supeφosition of subthreshold potential areas is an important feature. In many therapies, it is important to prevent action potentials being induced in gray matter 34 or dorsal horns 36 and 37, dorsal roots 38 and 40, dorsal lateral columns 47 or peripheral nerves 42 and 44 in order to minimize the possibility of causing pain, motor effects, or uncomfortable paresthesia. With the described techniques, the locus in which action potentials are induced (e.g., L3A, L6A, L9A, L12A, L15A, or L18A) can be manipulated to a desired area of the dorsal columns 46 without inducing action potentials in dorsal horns 36 and 37, gray matter 34 or dorsal lateral columns 47 or dorsal root ganglia 38 and 40. Moreover, the ability to move the locus in which action potentials are induced drastically reduces the accuracy necessary for surgically implanting electrodes 16A and 18 A, and may eliminate the need for surgical lead revisions. Another advantageous result from being able to determine the locus of excitation by controlling the area of suprathreshold potential from supeφosition of subthreshold potential areas is that the location of the two driven electrodes 16A and 18A and the return electrode with respect to each other is not critical to the practice of this invention. In contrast to the invention disclosed by Holsheimer et al. in U. S. Patent No. 5,501,703, the two driven electrodes and the return electrode in the present invention are not optimally spaced in line with respect to each other. In fact, the return electrode of the present invention can be located remotely from the driven electrodes 16A and 18A near a point up or down the spinal column or another part of the body carrying the spine being excited. Alternatively, there may be more than one return electrode within the body. Figure 11 illustrates a preferred timing relationship between pulse P7 applied to electrode
18A and pulse P8 applied to electrode 16 A. Currently available pulse generators use a biphasic pulse to insure no net direct current flows into the tissue. This is known as charge-balanced pulsing, and is accomplished by driving the pulse negative for a duration of time. For example, in Figure 11, pulse P8 has a net charge delivered proportional to A2*(T4-T3). This injected charge is balanced by the negative pulse P10, whose charge is proportional to A3*(T5-T4),
where A3«A2 and (T5-T4)»(T4-T3). Similar principles apply even if the first and second pulses are not of constant amplitude.
In a preferred embodiment, pulse P7 may be generated with a trailing negative pulse P9 from time T4 to time T5, so that the output on electrode 18A is substantially at neutral or 0 potential until the termination of pulse P8 at time T4. Having this delay in charge balancing prevents the loss of potential in adjacent tissue that otherwise would occur if pulse P9 immediately followed pulse P7 and overlapped with pulse P8, thus offsetting the benefit of pulse P8. At time T4 both negative pulses P9 and P10 begin in order to maintain the charge balance in tissue adjacent to the respective electrodes 18A and 16 A. The advantages of the invention described herein can be generalized to applications for exciting any electrically excitable tissue within any organism, in addition to such tissue within a spine. Moreover, the invention can be generalized to using more than two cathodal electrodes to generate more than two subthreshold areas to be supeφosed in generating the suprathreshold potential area. Accordingly, the forgoing description is by way of example only and is not intended to be limiting. The invention is limited only as defined in the following claims and equivalents thereof.
Claims
1. An apparatus for inducing action potentials at an adjustable locus of electrically excitable tissue of an organism, said apparatus comprising: a first electrode, adapted to be implanted adjacent said tissue, said first electrode being driven with a first pulse having a first amplitude and a first pulse width to generate a first subthreshold potential area in said tissue with respect to a return electrode disposed within said organism, and said first subthreshold potential area being determined by said first amplitude and said first pulse width; a second electrode, adapted to be implanted adjacent said tissue, said second electrode being driven with a second pulse having a second amplitude and a second pulse width after said first pulse has been applied to said first electrode to generate a second subthreshold potential area in said tissue with respect to said return electrode, and said second subthreshold potential area being determined by said second amplitude and said second pulse width, wherein a supeφosition of said first subthreshold area and said second subthreshold area results in a suprathreshold potential area of said adjustable locus where said action potentials are induced; and means for generating said first pulse with said first amplitude and said first pulse width that are adjustable for a first corresponding adjustment in said first subthreshold area and for generating said second pulse with said second amplitude and said second pulse width that are adjustable for a second corresponding adjustment in said second subthreshold area.
2. The apparatus of claim 1, wherein an increase in at least one of said first amplitude and said first pulse width results in an increase of said first subthreshold area and in an increase of said suprathreshold area toward said second electrode.
3. The apparatus of claim 2, wherein an increase in at least one of said second amplitude and said second pulse width of said second pulse results in an increase of said second subthreshold area and an increase of said suprathreshold area toward said first electrode.
4. The apparatus of claim 3, wherein an increase in at least one of said first amplitude and said first pulse width and a decrease in at least one of said second amplitude and said second pulse width results in a shift of said suprathreshold area toward said second electrode.
5. The apparatus of claim 4, wherein an increase in at least one of said second amplitude and said second pulse width and a decrease in at least one of said first amplitude and said first pulse width results in a shift of said suprathreshold area toward said first electrode.
6. The apparatus of claim 5, wherein said first pulse has a first begin time and a first end time and said second pulse has a second begin time and a second end time, and wherein said means for generating further includes means for adjusting a time delay between said first end time of said first pulse and said second begin time of said second pulse, wherein said time delay determines a size and location of said suprathreshold potential area.
7. The apparatus of claim 1, wherein said first pulse has a first begin time and a first end time and said second pulse has a second begin time and a second end time, and wherein said means for generating further includes means for adjusting a time delay between said first end time of said first pulse and said second begin time of said second pulse, wherein said time delay determines a size and location of said suprathreshold potential area.
8. The apparatus of claim 1, wherein said first pulse has a first weighted average time and said second pulse has a second weighted average time, wherein said means for generating further includes means for adjusting a time delay between said first and second weighted average times, wherein said time delay determines a size and location of said suprathreshold potential area.
9. The apparatus of claim 1, wherein said first pulse has a first peak time and said second pulse has a second peak time, wherein said means for generating further includes means for adjusting a time delay between said first and second peak times, wherein said time delay determines a size and location of said suprathreshold potential area.
10. The apparatus of claim 6, wherein an increase in said time delay results in a decrease in said size of said suprathreshold potential area and in a shifting of said suprathreshold potential area toward said first electrode.
11. The apparatus of claim 7, wherein an increase in said time delay results in a decrease in said size of said suprathreshold potential area and in a shifting of said suprathreshold potential area toward said first electrode.
12. The apparatus of claim 8, wherein an increase in said time delay results in a decrease in said size of said suprathreshold potential area and in a shifting of said suprathreshold potential area toward said first electrode.
13. The apparatus of claim 9, wherein an increase in said time delay results in a decrease in said size of said suprathreshold potential area and in a shifting of said suprathreshold potential area toward said first electrode.
14. A method for inducing action potentials at an adjustable locus of electrically excitable tissue within an organism, said method including the steps of:
A. applying a first pulse adjacent said tissue to generate a first subthreshold potential area in said tissue with respect to a return electrode disposed within said organism, said first pulse having a first amplitude and a first pulse width, and said first subthreshold potential area being determined by at least one of said first amplitude and said first pulse width;
B. applying a second pulse adjacent said tissue after said step A to generate a second subthreshold potential area in said tissue with respect to said return electrode, said second pulse having a second amplitude and a second pulse width, and said second subthreshold potential area being determined by at least one of said second amplitude and said second pulse width; C. generating a suprathreshold potential area of said adjustable locus of said tissue where said action potentials are induced from a supeφosition of said first and second subthreshold areas; and
D. adjusting at least one of said first and second amplitudes and of said first and second pulse widths to correspondingly adjust said locus of said tissue where said action potentials are induced.
15. The method of claim 14, wherein said step D further includes the step of:
E. increasing in at least one of said first amplitude and said first pulse width to cause an increase of said first subthreshold area and an increase of said suprathreshold area toward said second electrode.
16. The method of claim 15, wherein said step D further includes the step of:
F. increasing least one of said second amplitude and said second pulse width of said second pulse to cause an increase of said second subthreshold area and an increase of said suprathreshold area toward said first electrode.
17. The method of claim 16, wherein said step D further includes the step of:
G. increasing at least one of said first amplitude and said first pulse width and decreasing at least one of said second amplitude and said second pulse width to cause a shift of said suprathreshold area toward said second electrode.
18. The method of claim 17, wherein said step D further includes the step of:
H. increasing at least one of said second amplitude and said second pulse width and decreasing at least one of said first amplitude and said first pulse width to cause a shift of said suprathreshold area toward said first electrode.
19. The method of claim 18, wherein said first pulse has a first begin time and a first end time and said second pulse has a second begin time and a second end time, and wherein said method further includes the step of: I. adjusting a time delay between said first end time of said first pulse and said second begin time of said second pulse, wherein said time delay determines a size and location of said suprathreshold potential area.
20. The method of claim 14, wherein said first pulse has a first begin time and a first end time and said second pulse has a second begin time and a second end time, and wherein said method further includes the step of:
J. adjusting a time delay between said first end time of said first pulse and said second begin time of said second pulse, wherein said time delay determines a size and location of said suprathreshold potential area.
21. The method of claim 14, wherein said first pulse has a first weighted average time and said second pulse has a second weighted average time, and wherein said method further includes the step of: K. adjusting a time delay between said first and second weighted average times, wherein said time delay determines a size and location of said suprathreshold potential area.
22. The method of claim 14, wherein said first pulse has a first peak time and said second pulse has a second peak time, and wherein said method further includes the step of:
N. adjusting a time delay between said first and second peak times, wherein said time delay determines a size and location of said suprathreshold potential area.
23. The method of claim 19, wherein an increase in said time delay results in a decrease in said size of said suprathreshold potential area and in a shifting of said suprathreshold potential area toward said first electrode.
24. The method of claim 20, wherein an increase in said time delay results in a decrease in said size of said suprathreshold potential area and in a shifting of said suprathreshold potential area toward said first electrode.
25. The method of claim 21, wherein an increase in said time delay results in a decrease in said size of said suprathreshold potential area and in a shifting of said suprathreshold potential area toward said first electrode.
26. The method of claim 22, wherein an increase in said time delay results in a decrease in said size of said suprathreshold potential area and in a shifting of said suprathreshold potential area toward said first electrode.
27. A method for inducing action potentials at an adjustable locus of electrically excitable tissue within an organism, said method including the steps of:
A. applying a first pulse adjacent said tissue to generate a first subthreshold potential area in said tissue with respect to a return electrode disposed within said organism, said first pulse having a first amplitude and a first pulse width, and said first subthreshold potential area being determined by at least one of said first amplitude and said first pulse width;
B. applying a second pulse adjacent said tissue after said step A to generate a second subthreshold potential area in said tissue with respect to said return electrode, said second pulse having a second amplitude and a second pulse width, and said second subthreshold potential area being determined by at least one of said second amplitude and said second pulse width;
C. generating a suprathreshold potential area of said adjustable locus of said tissue where said action potentials are induced from a supeφosition of said first and second subthreshold areas; and
D. adjusting a time delay between said first pulse and said second pulse to correspondingly adjust said locus of said tissue where said action potentials are induced.
28. The method of claim 27, wherein an increase in said time delay results in a decrease in said size of said suprathreshold potential area and in a shifting of said suprathreshold potential area toward said first electrode.
29. The method of claim 2, further including the step of:
E. adjusting at least one of said first and second amplitudes and of said first and second pulse widths to correspondingly adjust said locus of said tissue where said action potentials are induced.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE69837481T DE69837481T2 (en) | 1997-03-10 | 1998-02-17 | DEVICE FOR ADJUSTING THE STIMULATION LOCATION OF ELECTRICALLY IRRITABLE TISSUE |
EP98906426A EP1007148B1 (en) | 1997-03-10 | 1998-02-17 | Apparatus for adjusting the locus of excitation of electrically excitable tissue |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/814,432 US5925070A (en) | 1996-04-04 | 1997-03-10 | Techniques for adjusting the locus of excitation of electrically excitable tissue |
US08/814,432 | 1997-03-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998040120A1 true WO1998040120A1 (en) | 1998-09-17 |
Family
ID=25215038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1998/002841 WO1998040120A1 (en) | 1997-03-10 | 1998-02-17 | Technique for adjusting the locus of excitation of electrically excitable tissue |
Country Status (4)
Country | Link |
---|---|
US (2) | US5925070A (en) |
EP (1) | EP1007148B1 (en) |
DE (1) | DE69837481T2 (en) |
WO (1) | WO1998040120A1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002009808A1 (en) * | 2000-07-26 | 2002-02-07 | Advanced Bionics Corporation | Rechargeable spinal cord stimulator system |
US6895280B2 (en) | 1999-07-27 | 2005-05-17 | Advanced Bionics Corporation | Rechargeable spinal cord stimulator system |
EP1562672A1 (en) * | 2002-07-30 | 2005-08-17 | Second Sight, LLC | Field focusing and mapping in an electrode array |
US7930037B2 (en) | 2003-09-30 | 2011-04-19 | Medtronic, Inc. | Field steerable electrical stimulation paddle, lead system, and medical device incorporating the same |
US8874235B1 (en) | 2008-12-12 | 2014-10-28 | Greatbatch Ltd. | Self fixing spinal cord stimulation paddle lead |
US10743064B2 (en) | 2000-03-31 | 2020-08-11 | Rovi Guides, Inc. | Systems and methods for improved audience measuring |
Families Citing this family (176)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6505078B1 (en) * | 1996-04-04 | 2003-01-07 | Medtronic, Inc. | Technique for adjusting the locus of excitation of electrically excitable tissue |
US6246912B1 (en) | 1996-06-27 | 2001-06-12 | Sherwood Services Ag | Modulated high frequency tissue modification |
US5983141A (en) | 1996-06-27 | 1999-11-09 | Radionics, Inc. | Method and apparatus for altering neural tissue function |
US5948007A (en) * | 1997-04-30 | 1999-09-07 | Medtronic, Inc. | Dual channel implantation neurostimulation techniques |
US6161048A (en) | 1997-06-26 | 2000-12-12 | Radionics, Inc. | Method and system for neural tissue modification |
DE69739334D1 (en) * | 1997-07-16 | 2009-05-07 | Metacure N V | Device for controlling a smooth muscle |
US6314325B1 (en) * | 1998-04-07 | 2001-11-06 | William R. Fitz | Nerve hyperpolarization method and apparatus for pain relief |
US6421566B1 (en) * | 1998-04-30 | 2002-07-16 | Medtronic, Inc. | Selective dorsal column stimulation in SCS, using conditioning pulses |
US6161047A (en) * | 1998-04-30 | 2000-12-12 | Medtronic Inc. | Apparatus and method for expanding a stimulation lead body in situ |
US6319241B1 (en) * | 1998-04-30 | 2001-11-20 | Medtronic, Inc. | Techniques for positioning therapy delivery elements within a spinal cord or a brain |
US7901400B2 (en) | 1998-10-23 | 2011-03-08 | Covidien Ag | Method and system for controlling output of RF medical generator |
US7137980B2 (en) | 1998-10-23 | 2006-11-21 | Sherwood Services Ag | Method and system for controlling output of RF medical generator |
US7364577B2 (en) | 2002-02-11 | 2008-04-29 | Sherwood Services Ag | Vessel sealing system |
US6253109B1 (en) * | 1998-11-05 | 2001-06-26 | Medtronic Inc. | System for optimized brain stimulation |
US8666495B2 (en) | 1999-03-05 | 2014-03-04 | Metacure Limited | Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar |
US6353762B1 (en) | 1999-04-30 | 2002-03-05 | Medtronic, Inc. | Techniques for selective activation of neurons in the brain, spinal cord parenchyma or peripheral nerve |
US7177690B2 (en) * | 1999-07-27 | 2007-02-13 | Advanced Bionics Corporation | Implantable system having rechargeable battery indicator |
US7228171B2 (en) * | 1999-10-19 | 2007-06-05 | The Johns Hopkins University | Signal analysis, heat flow management, and stimulation techniques to treat medical disorders |
US6882881B1 (en) * | 1999-10-19 | 2005-04-19 | The Johns Hopkins University | Techniques using heat flow management, stimulation, and signal analysis to treat medical disorders |
US7236831B2 (en) * | 2000-07-13 | 2007-06-26 | Northstar Neuroscience, Inc. | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US7672730B2 (en) | 2001-03-08 | 2010-03-02 | Advanced Neuromodulation Systems, Inc. | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US7831305B2 (en) | 2001-10-15 | 2010-11-09 | Advanced Neuromodulation Systems, Inc. | Neural stimulation system and method responsive to collateral neural activity |
US7305268B2 (en) | 2000-07-13 | 2007-12-04 | Northstar Neurscience, Inc. | Systems and methods for automatically optimizing stimulus parameters and electrode configurations for neuro-stimulators |
US20040176831A1 (en) * | 2000-07-13 | 2004-09-09 | Gliner Bradford Evan | Apparatuses and systems for applying electrical stimulation to a patient |
US7010351B2 (en) | 2000-07-13 | 2006-03-07 | Northstar Neuroscience, Inc. | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US7146217B2 (en) | 2000-07-13 | 2006-12-05 | Northstar Neuroscience, Inc. | Methods and apparatus for effectuating a change in a neural-function of a patient |
US20050021118A1 (en) * | 2000-07-13 | 2005-01-27 | Chris Genau | Apparatuses and systems for applying electrical stimulation to a patient |
US7756584B2 (en) | 2000-07-13 | 2010-07-13 | Advanced Neuromodulation Systems, Inc. | Methods and apparatus for effectuating a lasting change in a neural-function of a patient |
US7024247B2 (en) | 2001-10-15 | 2006-04-04 | Northstar Neuroscience, Inc. | Systems and methods for reducing the likelihood of inducing collateral neural activity during neural stimulation threshold test procedures |
US6928320B2 (en) * | 2001-05-17 | 2005-08-09 | Medtronic, Inc. | Apparatus for blocking activation of tissue or conduction of action potentials while other tissue is being therapeutically activated |
AU2002334749A1 (en) * | 2001-09-28 | 2003-04-07 | Northstar Neuroscience, Inc. | Methods and implantable apparatus for electrical therapy |
US7127296B2 (en) * | 2001-11-02 | 2006-10-24 | Advanced Bionics Corporation | Method for increasing the therapeutic ratio/usage range in a neurostimulator |
US20050010262A1 (en) * | 2002-02-01 | 2005-01-13 | Ali Rezai | Modulation of the pain circuitry to affect chronic pain |
US8233991B2 (en) | 2002-02-04 | 2012-07-31 | Boston Scientific Neuromodulation Corporation | Method for programming implantable device |
US7991482B2 (en) * | 2002-02-04 | 2011-08-02 | Boston Scientific Neuromodulation Corporation | Method for optimizing search for spinal cord stimulation parameter setting |
US7881805B2 (en) * | 2002-02-04 | 2011-02-01 | Boston Scientific Neuromodulation Corporation | Method for optimizing search for spinal cord stimulation parameter settings |
US7588581B2 (en) * | 2002-03-26 | 2009-09-15 | Medtronic, Inc. | Placement of chronic micro-catheter device and method |
US7221981B2 (en) | 2002-03-28 | 2007-05-22 | Northstar Neuroscience, Inc. | Electrode geometries for efficient neural stimulation |
US7697980B1 (en) * | 2002-04-03 | 2010-04-13 | Purdue Research Foundation | Technique for high spatial resolution, focused electrical stimulation of electrically-excitable tissue |
US20030204222A1 (en) * | 2002-04-26 | 2003-10-30 | Medtronic, Inc. | Recharge delay for an implantable medical device |
US20030208244A1 (en) * | 2002-04-26 | 2003-11-06 | Medtronic, Inc. | Voltage/current regulator improvements for an implantable medical device |
US6937891B2 (en) * | 2002-04-26 | 2005-08-30 | Medtronic, Inc. | Independent therapy programs in an implantable medical device |
US7483748B2 (en) * | 2002-04-26 | 2009-01-27 | Medtronic, Inc. | Programmable waveform pulses for an implantable medical device |
US7024246B2 (en) * | 2002-04-26 | 2006-04-04 | Medtronic, Inc | Automatic waveform output adjustment for an implantable medical device |
US7089057B2 (en) * | 2002-04-26 | 2006-08-08 | Medtronic, Inc. | Detection of possible failure of capacitive elements in an implantable medical device |
US6950706B2 (en) * | 2002-04-26 | 2005-09-27 | Medtronic, Inc. | Wave shaping for an implantable medical device |
CA2484875C (en) | 2002-05-06 | 2013-04-23 | Sherwood Services Ag | Method and system for optically detecting blood and controlling a generator during electrosurgery |
US20040193229A1 (en) * | 2002-05-17 | 2004-09-30 | Medtronic, Inc. | Gastric electrical stimulation for treatment of gastro-esophageal reflux disease |
US20040049121A1 (en) * | 2002-09-06 | 2004-03-11 | Uri Yaron | Positioning system for neurological procedures in the brain |
US7236830B2 (en) | 2002-12-10 | 2007-06-26 | Northstar Neuroscience, Inc. | Systems and methods for enhancing or optimizing neural stimulation therapy for treating symptoms of Parkinson's disease and/or other movement disorders |
US20050075680A1 (en) | 2003-04-18 | 2005-04-07 | Lowry David Warren | Methods and systems for intracranial neurostimulation and/or sensing |
US6959215B2 (en) | 2002-12-09 | 2005-10-25 | Northstar Neuroscience, Inc. | Methods for treating essential tremor |
US7044948B2 (en) | 2002-12-10 | 2006-05-16 | Sherwood Services Ag | Circuit for controlling arc energy from an electrosurgical generator |
CA2523540A1 (en) * | 2003-04-24 | 2005-01-06 | Northstar Neuroscience, Inc. | Systems and methods for facilitating and/or effectuating development, rehabilitation, restoration, and/or recovery of visual function through neural stimulation |
JP2006525096A (en) | 2003-05-01 | 2006-11-09 | シャーウッド・サービシーズ・アクチェンゲゼルシャフト | Method and system for programming and controlling an electrosurgical generator system |
US7620454B2 (en) * | 2003-05-19 | 2009-11-17 | Medtronic, Inc. | Gastro-electric stimulation for reducing the acidity of gastric secretions or reducing the amounts thereof |
US7742818B2 (en) * | 2003-05-19 | 2010-06-22 | Medtronic, Inc. | Gastro-electric stimulation for increasing the acidity of gastric secretions or increasing the amounts thereof |
US7254443B2 (en) * | 2003-06-06 | 2007-08-07 | Medtronic, Inc. | Implantable medical device including a hermetic connector block extension |
US8792985B2 (en) | 2003-07-21 | 2014-07-29 | Metacure Limited | Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar |
AU2004261290A1 (en) | 2003-08-01 | 2005-02-10 | Northstar Neuroscience, Inc. | Apparatus and methods for applying neural stimulation to a patient |
US8489196B2 (en) * | 2003-10-03 | 2013-07-16 | Medtronic, Inc. | System, apparatus and method for interacting with a targeted tissue of a patient |
EP2258294B1 (en) | 2003-10-23 | 2013-01-09 | Covidien AG | Redundant temperature monitoring in electrosurgical systems for safety mitigation |
EP1676108B1 (en) | 2003-10-23 | 2017-05-24 | Covidien AG | Thermocouple measurement circuit |
US7396336B2 (en) | 2003-10-30 | 2008-07-08 | Sherwood Services Ag | Switched resonant ultrasonic power amplifier system |
US7131860B2 (en) | 2003-11-20 | 2006-11-07 | Sherwood Services Ag | Connector systems for electrosurgical generator |
US7236834B2 (en) | 2003-12-19 | 2007-06-26 | Medtronic, Inc. | Electrical lead body including an in-line hermetic electronic package and implantable medical device using the same |
US8060207B2 (en) | 2003-12-22 | 2011-11-15 | Boston Scientific Scimed, Inc. | Method of intravascularly delivering stimulation leads into direct contact with tissue |
US20050137646A1 (en) * | 2003-12-22 | 2005-06-23 | Scimed Life Systems, Inc. | Method of intravascularly delivering stimulation leads into brain |
US7766905B2 (en) | 2004-02-12 | 2010-08-03 | Covidien Ag | Method and system for continuity testing of medical electrodes |
US7295875B2 (en) * | 2004-02-20 | 2007-11-13 | Boston Scientific Scimed, Inc. | Method of stimulating/sensing brain with combination of intravascularly and non-vascularly delivered leads |
US7780662B2 (en) | 2004-03-02 | 2010-08-24 | Covidien Ag | Vessel sealing system using capacitive RF dielectric heating |
US20050203600A1 (en) | 2004-03-12 | 2005-09-15 | Scimed Life Systems, Inc. | Collapsible/expandable tubular electrode leads |
US7590454B2 (en) | 2004-03-12 | 2009-09-15 | Boston Scientific Neuromodulation Corporation | Modular stimulation lead network |
US7177702B2 (en) | 2004-03-12 | 2007-02-13 | Scimed Life Systems, Inc. | Collapsible/expandable electrode leads |
US7231260B2 (en) | 2004-05-06 | 2007-06-12 | Boston Scientific Scimed, Inc. | Intravascular self-anchoring electrode body with arcuate springs, spring loops, or arms |
US7346382B2 (en) | 2004-07-07 | 2008-03-18 | The Cleveland Clinic Foundation | Brain stimulation models, systems, devices, and methods |
US7483747B2 (en) | 2004-07-15 | 2009-01-27 | Northstar Neuroscience, Inc. | Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy |
US7286879B2 (en) | 2004-07-16 | 2007-10-23 | Boston Scientific Scimed, Inc. | Method of stimulating fastigium nucleus to treat neurological disorders |
US7628786B2 (en) | 2004-10-13 | 2009-12-08 | Covidien Ag | Universal foot switch contact port |
US9050455B2 (en) | 2004-10-21 | 2015-06-09 | Medtronic, Inc. | Transverse tripole neurostimulation methods, kits and systems |
US7565200B2 (en) | 2004-11-12 | 2009-07-21 | Advanced Neuromodulation Systems, Inc. | Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of Parkinson's disease, other movement disorders, and/or drug side effects |
US7937160B2 (en) * | 2004-12-10 | 2011-05-03 | Boston Scientific Neuromodulation Corporation | Methods for delivering cortical electrode leads into patient's head |
US9474564B2 (en) | 2005-03-31 | 2016-10-25 | Covidien Ag | Method and system for compensating for external impedance of an energy carrying component when controlling an electrosurgical generator |
US20070073354A1 (en) * | 2005-09-26 | 2007-03-29 | Knudson Mark B | Neural blocking therapy |
US8929991B2 (en) | 2005-10-19 | 2015-01-06 | Advanced Neuromodulation Systems, Inc. | Methods for establishing parameters for neural stimulation, including via performance of working memory tasks, and associated kits |
US7729773B2 (en) | 2005-10-19 | 2010-06-01 | Advanced Neuromodualation Systems, Inc. | Neural stimulation and optical monitoring systems and methods |
US7856264B2 (en) * | 2005-10-19 | 2010-12-21 | Advanced Neuromodulation Systems, Inc. | Systems and methods for patient interactive neural stimulation and/or chemical substance delivery |
US20070088404A1 (en) * | 2005-10-19 | 2007-04-19 | Allen Wyler | Methods and systems for improving neural functioning, including cognitive functioning and neglect disorders |
US8734438B2 (en) | 2005-10-21 | 2014-05-27 | Covidien Ag | Circuit and method for reducing stored energy in an electrosurgical generator |
US8589316B2 (en) | 2009-08-27 | 2013-11-19 | The Cleveland Clinic Foundation | System and method to estimate region of tissue activation |
US7947039B2 (en) | 2005-12-12 | 2011-05-24 | Covidien Ag | Laparoscopic apparatus for performing electrosurgical procedures |
US20070142863A1 (en) * | 2005-12-15 | 2007-06-21 | Kerry Bradley | Apparatus and methods for stimulating tissue |
US8685016B2 (en) | 2006-01-24 | 2014-04-01 | Covidien Ag | System and method for tissue sealing |
CA2575392C (en) | 2006-01-24 | 2015-07-07 | Sherwood Services Ag | System and method for tissue sealing |
US8216223B2 (en) | 2006-01-24 | 2012-07-10 | Covidien Ag | System and method for tissue sealing |
CA2574934C (en) | 2006-01-24 | 2015-12-29 | Sherwood Services Ag | System and method for closed loop monitoring of monopolar electrosurgical apparatus |
US8147485B2 (en) | 2006-01-24 | 2012-04-03 | Covidien Ag | System and method for tissue sealing |
CA2574935A1 (en) | 2006-01-24 | 2007-07-24 | Sherwood Services Ag | A method and system for controlling an output of a radio-frequency medical generator having an impedance based control algorithm |
US9186200B2 (en) | 2006-01-24 | 2015-11-17 | Covidien Ag | System and method for tissue sealing |
US7513896B2 (en) | 2006-01-24 | 2009-04-07 | Covidien Ag | Dual synchro-resonant electrosurgical apparatus with bi-directional magnetic coupling |
US7651493B2 (en) | 2006-03-03 | 2010-01-26 | Covidien Ag | System and method for controlling electrosurgical snares |
US7648499B2 (en) | 2006-03-21 | 2010-01-19 | Covidien Ag | System and method for generating radio frequency energy |
US7689289B2 (en) * | 2006-03-22 | 2010-03-30 | Medtronic, Inc. | Technique for adjusting the locus of excitation of electrically excitable tissue with paired pulses |
US7805197B2 (en) | 2006-04-07 | 2010-09-28 | Boston Scientific Neuromodulation Corporation | System and method using multiple timing channels for electrode adjustment during set up of an implanted stimulator device |
US7651492B2 (en) | 2006-04-24 | 2010-01-26 | Covidien Ag | Arc based adaptive control system for an electrosurgical unit |
US8753334B2 (en) | 2006-05-10 | 2014-06-17 | Covidien Ag | System and method for reducing leakage current in an electrosurgical generator |
EP2040790B1 (en) | 2006-06-19 | 2012-12-12 | Highland Instruments, Inc. | Apparatus for stimulation of biological tissue |
US9913976B2 (en) | 2006-06-19 | 2018-03-13 | Highland Instruments, Inc. | Systems and methods for stimulating and monitoring biological tissue |
US8718758B2 (en) * | 2006-06-19 | 2014-05-06 | Highland Instruments, Inc. | Interface apparatus for stimulation of biological tissue |
US8892200B2 (en) | 2006-06-19 | 2014-11-18 | Highland Instruments, Inc. | Systems and methods for stimulating tissue using focused energy |
US7731717B2 (en) | 2006-08-08 | 2010-06-08 | Covidien Ag | System and method for controlling RF output during tissue sealing |
US8034049B2 (en) | 2006-08-08 | 2011-10-11 | Covidien Ag | System and method for measuring initial tissue impedance |
US7637907B2 (en) * | 2006-09-19 | 2009-12-29 | Covidien Ag | System and method for return electrode monitoring |
US7794457B2 (en) | 2006-09-28 | 2010-09-14 | Covidien Ag | Transformer for RF voltage sensing |
US8777941B2 (en) | 2007-05-10 | 2014-07-15 | Covidien Lp | Adjustable impedance electrosurgical electrodes |
US7834484B2 (en) | 2007-07-16 | 2010-11-16 | Tyco Healthcare Group Lp | Connection cable and method for activating a voltage-controlled generator |
US8216220B2 (en) | 2007-09-07 | 2012-07-10 | Tyco Healthcare Group Lp | System and method for transmission of combined data stream |
US8512332B2 (en) | 2007-09-21 | 2013-08-20 | Covidien Lp | Real-time arc control in electrosurgical generators |
DK2197534T3 (en) | 2007-09-25 | 2018-06-14 | Neosync Inc | DEVICE WITH TWO ROTATE PERMANENT MAGNETS FOR APPLYING ON THE HEAD OF AN INDIVIDUAL |
US9220889B2 (en) | 2008-02-11 | 2015-12-29 | Intelect Medical, Inc. | Directional electrode devices with locating features |
US8019440B2 (en) | 2008-02-12 | 2011-09-13 | Intelect Medical, Inc. | Directional lead assembly |
US8548596B2 (en) * | 2008-04-29 | 2013-10-01 | Medtronic, Inc. | Therapy program modification based on an energy threshold |
EP2307093B1 (en) * | 2008-04-29 | 2012-07-25 | Medtronic, Inc. | Therapy program modification based on an energy threshold |
US9272153B2 (en) | 2008-05-15 | 2016-03-01 | Boston Scientific Neuromodulation Corporation | VOA generation system and method using a fiber specific analysis |
US8226639B2 (en) | 2008-06-10 | 2012-07-24 | Tyco Healthcare Group Lp | System and method for output control of electrosurgical generator |
US20090326608A1 (en) * | 2008-06-25 | 2009-12-31 | Huynh Jeffrey C | Method of electrically stimulating tissue of a patient by shifting a locus of stimulation and system employing the same |
US8255057B2 (en) | 2009-01-29 | 2012-08-28 | Nevro Corporation | Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions |
US8262652B2 (en) | 2009-01-12 | 2012-09-11 | Tyco Healthcare Group Lp | Imaginary impedance process monitoring and intelligent shut-off |
US8452417B2 (en) * | 2009-07-23 | 2013-05-28 | Rosa M. Navarro | System and method for treating pain with peripheral and spinal neuromodulation |
US8465408B2 (en) | 2009-08-06 | 2013-06-18 | Neosync, Inc. | Systems and methods for modulating the electrical activity of a brain using neuro-EEG synchronization therapy |
KR101830051B1 (en) * | 2009-11-05 | 2018-02-19 | 코닌클리케 필립스 엔.브이. | Electrical muscle stimulation |
EP3744393B1 (en) | 2009-11-12 | 2022-04-27 | Neosync, INC. | Systems and methods for neuro-eeg syncronization |
WO2011068997A1 (en) | 2009-12-02 | 2011-06-09 | The Cleveland Clinic Foundation | Reversing cognitive-motor impairments in patients having a neuro-degenerative disease using a computational modeling approach to deep brain stimulation programming |
US8934975B2 (en) | 2010-02-01 | 2015-01-13 | Metacure Limited | Gastrointestinal electrical therapy |
US8913804B2 (en) | 2010-06-14 | 2014-12-16 | Boston Scientific Neuromodulation Corporation | Programming interface for spinal cord neuromodulation |
WO2012054573A2 (en) | 2010-10-21 | 2012-04-26 | Highland Instruments | Systems for detecting a condition |
JP2014522247A (en) | 2011-03-29 | 2014-09-04 | ボストン サイエンティフィック ニューロモデュレイション コーポレイション | System and method for lead positioning |
US9592389B2 (en) | 2011-05-27 | 2017-03-14 | Boston Scientific Neuromodulation Corporation | Visualization of relevant stimulation leadwire electrodes relative to selected stimulation information |
US8751008B2 (en) | 2011-08-09 | 2014-06-10 | Boston Scientific Neuromodulation Corporation | Remote control data management with correlation of patient condition to stimulation settings and/or with clinical mode providing a mismatch between settings and interface data |
US8594783B2 (en) | 2011-08-24 | 2013-11-26 | Highland Instruments, Inc. | Systems and methods for stimulating cellular function in tissue |
US9649502B2 (en) | 2011-11-14 | 2017-05-16 | Neosync, Inc. | Devices and methods of low frequency magnetic stimulation therapy |
US9149635B2 (en) | 2012-04-27 | 2015-10-06 | Medtronic, Inc. | Stimulation waveform generator for an implantable medical device |
US9604067B2 (en) | 2012-08-04 | 2017-03-28 | Boston Scientific Neuromodulation Corporation | Techniques and methods for storing and transferring registration, atlas, and lead information between medical devices |
WO2014036079A2 (en) | 2012-08-28 | 2014-03-06 | Boston Scientific Neuromodulation Corporation | Parameter visualization, selection, and annotation interface |
WO2014047152A1 (en) | 2012-09-19 | 2014-03-27 | The Regents Of The University Of Michigan | Advanced intraoperative neural targeting system and method |
US9792412B2 (en) | 2012-11-01 | 2017-10-17 | Boston Scientific Neuromodulation Corporation | Systems and methods for VOA model generation and use |
US9872719B2 (en) | 2013-07-24 | 2018-01-23 | Covidien Lp | Systems and methods for generating electrosurgical energy using a multistage power converter |
US9655670B2 (en) | 2013-07-29 | 2017-05-23 | Covidien Lp | Systems and methods for measuring tissue impedance through an electrosurgical cable |
US9192759B2 (en) | 2014-03-31 | 2015-11-24 | Dennison Hamilton | System and method for stabilizing implanted spinal cord stimulators |
US9959388B2 (en) | 2014-07-24 | 2018-05-01 | Boston Scientific Neuromodulation Corporation | Systems, devices, and methods for providing electrical stimulation therapy feedback |
US10265528B2 (en) | 2014-07-30 | 2019-04-23 | Boston Scientific Neuromodulation Corporation | Systems and methods for electrical stimulation-related patient population volume analysis and use |
US10272247B2 (en) | 2014-07-30 | 2019-04-30 | Boston Scientific Neuromodulation Corporation | Systems and methods for stimulation-related volume analysis, creation, and sharing with integrated surgical planning and stimulation programming |
US10588576B2 (en) | 2014-08-15 | 2020-03-17 | Neosync, Inc. | Methods and device for determining a valid intrinsic frequency |
WO2016057544A1 (en) | 2014-10-07 | 2016-04-14 | Boston Scientific Neuromodulation Corporation | Systems, devices, and methods for electrical stimulation using feedback to adjust stimulation parameters |
USD759803S1 (en) | 2014-10-28 | 2016-06-21 | Highland Instruments, Inc. | Adjustable headpiece with anatomical markers |
US9956419B2 (en) | 2015-05-26 | 2018-05-01 | Boston Scientific Neuromodulation Corporation | Systems and methods for analyzing electrical stimulation and selecting or manipulating volumes of activation |
US10780283B2 (en) | 2015-05-26 | 2020-09-22 | Boston Scientific Neuromodulation Corporation | Systems and methods for analyzing electrical stimulation and selecting or manipulating volumes of activation |
EP3280490B1 (en) | 2015-06-29 | 2021-09-01 | Boston Scientific Neuromodulation Corporation | Systems for selecting stimulation parameters based on stimulation target region, effects, or side effects |
ES2940303T3 (en) | 2015-06-29 | 2023-05-05 | Boston Scient Neuromodulation Corp | Stimulation parameter selection systems by use of targets and direction |
EP3359252B1 (en) | 2015-10-09 | 2020-09-09 | Boston Scientific Neuromodulation Corporation | System and methods for clinical effects mapping for directional stimulations leads |
US11318310B1 (en) | 2015-10-26 | 2022-05-03 | Nevro Corp. | Neuromodulation for altering autonomic functions, and associated systems and methods |
US10716942B2 (en) | 2016-04-25 | 2020-07-21 | Boston Scientific Neuromodulation Corporation | System and methods for directional steering of electrical stimulation |
CN109416937A (en) | 2016-06-24 | 2019-03-01 | 波士顿科学神经调制公司 | The system and method for visual analysis for clinical effectiveness |
WO2018044881A1 (en) | 2016-09-02 | 2018-03-08 | Boston Scientific Neuromodulation Corporation | Systems and methods for visualizing and directing stimulation of neural elements |
US10780282B2 (en) | 2016-09-20 | 2020-09-22 | Boston Scientific Neuromodulation Corporation | Systems and methods for steering electrical stimulation of patient tissue and determining stimulation parameters |
CN109803719B (en) | 2016-10-14 | 2023-05-26 | 波士顿科学神经调制公司 | System and method for closed loop determination of stimulation parameter settings for an electrical simulation system |
ES2871008T3 (en) | 2017-01-03 | 2021-10-28 | Boston Scient Neuromodulation Corp | Systems and Procedures for Selecting MRI-Compatible Stimulation Parameters |
EP3519043B1 (en) | 2017-01-10 | 2020-08-12 | Boston Scientific Neuromodulation Corporation | Systems and methods for creating stimulation programs based on user-defined areas or volumes |
JP1602547S (en) | 2017-01-17 | 2018-04-23 | ||
US10625082B2 (en) | 2017-03-15 | 2020-04-21 | Boston Scientific Neuromodulation Corporation | Visualization of deep brain stimulation efficacy |
US11357986B2 (en) | 2017-04-03 | 2022-06-14 | Boston Scientific Neuromodulation Corporation | Systems and methods for estimating a volume of activation using a compressed database of threshold values |
US10716505B2 (en) | 2017-07-14 | 2020-07-21 | Boston Scientific Neuromodulation Corporation | Systems and methods for estimating clinical effects of electrical stimulation |
WO2019036180A1 (en) | 2017-08-15 | 2019-02-21 | Boston Scientific Neuromodulation Corporation | Systems and methods for controlling electrical stimulation using multiple stimulation fields |
AU2019260740B2 (en) | 2018-04-27 | 2022-05-19 | Boston Scientific Neuromodulation Corporation | Multi-mode electrical stimulation systems and methods of making and using |
US11285329B2 (en) | 2018-04-27 | 2022-03-29 | Boston Scientific Neuromodulation Corporation | Systems and methods for visualizing and programming electrical stimulation |
US11590352B2 (en) | 2019-01-29 | 2023-02-28 | Nevro Corp. | Ramped therapeutic signals for modulating inhibitory interneurons, and associated systems and methods |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4548203A (en) * | 1982-06-01 | 1985-10-22 | Purdue Research Foundation | Sequential-pulse, multiple pathway defibrillation method |
US5121754A (en) | 1990-08-21 | 1992-06-16 | Medtronic, Inc. | Lateral displacement percutaneously inserted epidural lead |
WO1995019804A1 (en) | 1994-01-24 | 1995-07-27 | Medtronic, Inc. | Multichannel apparatus for epidural spinal cord stimulation |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1935138A (en) * | 1931-06-30 | 1933-11-14 | Ind Waste Eliminators Ltd | Apparatus for use in electrically stunning animals |
US3822708A (en) * | 1972-12-07 | 1974-07-09 | Clinical Technology Corp | Electrical spinal cord stimulating device and method for management of pain |
US4813418A (en) * | 1987-02-02 | 1989-03-21 | Staodynamics, Inc. | Nerve fiber stimulation using symmetrical biphasic waveform applied through plural equally active electrodes |
US5178161A (en) * | 1988-09-02 | 1993-01-12 | The Board Of Trustees Of The Leland Stanford Junior University | Microelectronic interface |
US5314458A (en) * | 1990-06-01 | 1994-05-24 | University Of Michigan | Single channel microstimulator |
US5370665A (en) * | 1990-08-10 | 1994-12-06 | Medtronic, Inc. | Medical stimulator with multiple operational amplifier output stimulation circuits |
US5324309A (en) * | 1992-09-25 | 1994-06-28 | Medtronic, Inc. | Overlapping pulse cardioversion or defibrillation |
GB9302335D0 (en) * | 1993-02-05 | 1993-03-24 | Macdonald Alexander J R | Electrotherapeutic apparatus |
US5507788A (en) * | 1994-08-11 | 1996-04-16 | The Regents Of The University Of California | Method and apparatus for controlling skeletal muscle fatigue during electrical stimulation |
US5713922A (en) * | 1996-04-25 | 1998-02-03 | Medtronic, Inc. | Techniques for adjusting the locus of excitation of neural tissue in the spinal cord or brain |
-
1997
- 1997-03-10 US US08/814,432 patent/US5925070A/en not_active Expired - Lifetime
-
1998
- 1998-02-17 DE DE69837481T patent/DE69837481T2/en not_active Expired - Lifetime
- 1998-02-17 EP EP98906426A patent/EP1007148B1/en not_active Expired - Lifetime
- 1998-02-17 WO PCT/US1998/002841 patent/WO1998040120A1/en active IP Right Grant
-
1999
- 1999-05-17 US US09/312,470 patent/US6083252A/en not_active Expired - Lifetime
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4548203A (en) * | 1982-06-01 | 1985-10-22 | Purdue Research Foundation | Sequential-pulse, multiple pathway defibrillation method |
US5121754A (en) | 1990-08-21 | 1992-06-16 | Medtronic, Inc. | Lateral displacement percutaneously inserted epidural lead |
WO1995019804A1 (en) | 1994-01-24 | 1995-07-27 | Medtronic, Inc. | Multichannel apparatus for epidural spinal cord stimulation |
US5501703A (en) * | 1994-01-24 | 1996-03-26 | Medtronic, Inc. | Multichannel apparatus for epidural spinal cord stimulator |
Non-Patent Citations (1)
Title |
---|
See also references of EP1007148A4 |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6895280B2 (en) | 1999-07-27 | 2005-05-17 | Advanced Bionics Corporation | Rechargeable spinal cord stimulator system |
US10743064B2 (en) | 2000-03-31 | 2020-08-11 | Rovi Guides, Inc. | Systems and methods for improved audience measuring |
WO2002009808A1 (en) * | 2000-07-26 | 2002-02-07 | Advanced Bionics Corporation | Rechargeable spinal cord stimulator system |
EP1518584B1 (en) * | 2000-07-26 | 2008-10-29 | Boston Scientific Neuromodulation Corporation | Stimulator system |
EP1562672A1 (en) * | 2002-07-30 | 2005-08-17 | Second Sight, LLC | Field focusing and mapping in an electrode array |
EP1562672A4 (en) * | 2002-07-30 | 2009-12-23 | Second Sight Medical Prod Inc | Field focusing and mapping in an electrode array |
EP2839858A1 (en) * | 2002-07-30 | 2015-02-25 | Second Sight Medical Products, Inc. | Field focusing and mapping in an electrode array |
US7930037B2 (en) | 2003-09-30 | 2011-04-19 | Medtronic, Inc. | Field steerable electrical stimulation paddle, lead system, and medical device incorporating the same |
US9867980B2 (en) | 2003-09-30 | 2018-01-16 | Medtronic, Inc. | Field steerable electrical stimulation paddle, lead system, and medical device incorporating the same |
US8874235B1 (en) | 2008-12-12 | 2014-10-28 | Greatbatch Ltd. | Self fixing spinal cord stimulation paddle lead |
Also Published As
Publication number | Publication date |
---|---|
DE69837481T2 (en) | 2007-12-13 |
EP1007148B1 (en) | 2007-04-04 |
DE69837481D1 (en) | 2007-05-16 |
EP1007148A1 (en) | 2000-06-14 |
EP1007148A4 (en) | 2003-09-10 |
US6083252A (en) | 2000-07-04 |
US5925070A (en) | 1999-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1007148B1 (en) | Apparatus for adjusting the locus of excitation of electrically excitable tissue | |
US6988006B2 (en) | Technique for adjusting the locus of excitation of electrically excitable tissue | |
US7689289B2 (en) | Technique for adjusting the locus of excitation of electrically excitable tissue with paired pulses | |
EP1015070B1 (en) | Dual channel implantation neurostimulation techniques | |
US5713922A (en) | Techniques for adjusting the locus of excitation of neural tissue in the spinal cord or brain | |
EP1868680B1 (en) | Apparatus for detecting position and migration of neurostimulation leads | |
EP1181949B1 (en) | Multichannel stimulator electronics | |
US9375575B2 (en) | Short duration pre-pulsing to reduce stimulation-evoked side-effetcs | |
EP2274048B1 (en) | Current steering for an implantable stimulator device involving fractionalized stimulation pulses | |
EP3253444B1 (en) | Method and apparatus for programming charge recovery in neurostimulation waveform | |
JP5188494B2 (en) | System and method using multiple timing channels for electrode adjustment during implant stimulator setup | |
US7127296B2 (en) | Method for increasing the therapeutic ratio/usage range in a neurostimulator | |
AU1731095A (en) | Multichannel apparatus for epidural spinal cord stimulation | |
WO1997037721A1 (en) | Techniques for adjusting the locus of excitation of electrically excitable tissue |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1998906426 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1998906426 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1998906426 Country of ref document: EP |